Celcuity To Present at Upcoming TD Cowen and Jefferies Investor Conferences
MINNEAPOLIS, May 21, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies...
Cancer
Tonix Pharmaceuticals Announces First Patient Dosed in Phase 2 OASIS Study of TNX-102 SL for Reduction of Acute Stress Reaction
Investigator-initiated Phase 2 trial to evaluate TNX-102 SL’s potential to reduce severity of acute stress reaction (ASR) and frequency of...
Tango Therapeutics Announces First Patient Dosed in TNG456 Phase 1/2 Trial in Patients With MTAP-deleted Glioblastomas and Other Solid Tumors
BOSTON, May 21, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering the...
Castle Biosciences to Present at the 2025 Jefferies Global Healthcare Conference
FRIENDSWOOD, Texas, May 21, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that...
GenVivo Highlights Non-Integrating Retroviral Vector Technology with Persistent Payload Expression at the 2025 Retroviruses Meeting
Retroviral vectors that are both non-replicating and non-integrating represent a novel and attractive tool that has potential advantages for gene...
The 10,000 Brains Project Launches the “Path-ND” Digital Brain Banking Program to Transform Neurodegenerative Disease Research
Funding from the Kissick Family Foundation Expands Frontotemporal Dementia Data; New Partnership with The Michael J. Fox Foundation Enhances Parkinson's Research OAKLAND, Calif., May 20, 2025 /PRNewswire/ -- The...
Clinical Decision Support Systems (CDSS) Market worth US$3.89 billion by 2030 with 9.6% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., May 20, 2025 /PRNewswire/ -- The global clinical decision support systems market , valued at US$2.25 billion in...
myTomorrows Surpasses 15,000 Patient Matches through AI-Powered Platform and Personalized Services
On International Clinical Trials Day, myTomorrows, whose AI-powered platform connects patients with pre-approval treatments, celebrates the milestone of successfully matching...
Mopec Group and Lumea Announce Strategic Partnership to Advance Workflow-Driven Innovation in Pathology
MADISON HEIGHTS, Mich., May 20, 2025 /PRNewswire/ -- Mopec Group, the industry leader of anatomic and forensic pathology equipment and technology,...
STAND UP TO CANCER PRESIDENT AND CEO JULIAN ADAMS TO SPEAK AT NATIONAL ACADEMIES WORKSHOP
LOS ANGELES, May 20, 2025 /PRNewswire/ -- Stand Up To Cancer® (SU2C) President and CEO Julian Adams, Ph.D., will speak...
Trial Library Works with Texas Oncology to Enhance Patient Clinical Trial Navigation
SAN FRANCISCO, May 20, 2025 /PRNewswire/ -- Trial Library, a technology company focused on equitable access to oncology clinical trials,...
From Retina Scans to Cancer Trials, AI Is Taking Over the Exam Room
Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 20, 2025 /PRNewswire/ -- Equity Insider...
New Study Published on the Safety and Feasibility of Pulsed Electric Field Ablation for Early-Stage Non-Small Cell Lung Cancer Prior to Surgical Resection
Innovative technology offers promising non-thermal approach to soft tissue ablation without compromising sensitive structures. REDWOOD CITY, Calif., May 20, 2025...
Rad AI Announces Strategic Investments from Four Leading Health Systems to Advance Enterprise AI in Healthcare
SAN FRANCISCO, May 20, 2025 /PRNewswire/ -- Rad AI today announced an additional $8 million strategic investment to its latest...
Mobile-health Network Solutions Signs MOU to Add AI-enabled Dental Scans and Oral Health Screening to its Telemedicine Platform
Singapore, Singapore--(Newsfile Corp. - May 20, 2025) - Mobile-health Network Solutions (Nasdaq: MNDR) ("MNDR" or "the Company"), a leading MedTech...
Teal Health Announces Publication of SELF-CERV Study Results in JAMA Network Open Following FDA Approval of Teal Wand™ for At-Home HPV Screening
SAN FRANCISCO, May 19, 2025 /PRNewswire/ -- Following its recent FDA approval, Teal Health® announced the publication of its multi-center pivotal...
Lunit Surpasses 1 Million Mammograms in U.S. One Year After Volpara Acquisition
Building on Volpara's breast health expertise, Lunit strengthens its U.S. presence—now delivering AI-powered breast cancer screening across 200 imaging sites...
Cortechs.ai and ALZ-NET Announce Strategic Collaboration to Improve Alzheimer’s Disease Care Through AI-Driven Imaging
SAN DIEGO, May 19, 2025 /PRNewswire/ -- Cortechs.ai, a global leader in AI-driven neuroimaging solutions, today announced a strategic collaboration...
GT Biopharma Advances GTB-3650 Phase 1 Trial to Cohort 2 Following Successful Initial Human Dosing and Evidence of Early Immune Activation Signals
Following the formal safety review of Cohort 1, no safety or tolerability issues were observed, allowing the company to move...
Prime Medicine Announces Strategic Restructuring to Focus on Opportunities in Large Genetic Liver Diseases, Cystic Fibrosis, and Partnered Programs Alongside CEO Leadership Transition
-- Initial positive data from Phase 1/2 clinical trial of PM359 in CGD provide clinical proof-of-concept for Prime Editing as...